IL1B and Alzheimer disease: Therefore, inhibiting Aβ‐induced microglial activation can reduce the production of TNF‐α, IL‐1β, and IL‐6, thereby reducing Aβ deposition and neuron death, blocking the cycle of inflammatory toxicity, and improving behavioral performance in AD mice.